Norvir Advisory

The Problem Consequences Tolerability Temperature Portability Adherence Regimens FAQs Ask Share Referrals Committee Norvir Home Search What's New Site Help Email List Links IAPAC Home

Notice: This is an IAPAC initiative that is under the sole direction of the IAPAC Norvir Advisory Committee. Contents of the Norvir Advisory section of the IAPAC Web site are subject to the approval of the chair of the advisory committee and will reflect the recommendations of the committee members. Abbott Laboratories has no input in the content of the Norvir Advisory section of the IAPAC Web site.

Abbott Laboratories Receives U.S. FDA Approval
for Reformulated Norvir (Ritonavir) Capsule

	About the IAPAC Norvir Advisory The IAPAC Norvir Advisory Frequently Asked Questions
	Description of the Problem
	Consequences of the Problem
	Tolerability Issues with Norvir Liquid Formulation
	Temperature Issues with Norvir Liquid Formulation
	Portability
	Adherence Issues
	When Should Consideration Be Given to Switch to Other Antiviral Regimens?
	Frequently Asked Questions
	What's New on the IAPAC Norvir Advisory Subscribe to receive email notices of site updates and additions.
	Search the IAPAC Norvir Advisory Site
	Share Your Experience or Ask a Question
	Physicians' Access to Antiviral Specialists
	How to Use the IAPAC Norvir Advisory Site

About IAPAC  Education  Advocacy  Publications Join IAPAC  Contact Us  Search  Links  Main Page ©2002, International Association of Physicians in AIDS Care 33 North LaSalle Street, Suite 1700, Chicago, Illinois 60602-2601 Email: iapac@iapac.org  Web: http://www.iapac.org Phone: 312 795-4930  Fax: 312 795-4938